4//SEC Filing
Longsworth Todd Christopher 4
Accession 0001645113-21-000026
CIK 0001645113other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:44 PM ET
Size
9.1 KB
Accession
0001645113-21-000026
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Longsworth Todd Christopher
General Counsel
Transactions
- Sale
Restricted Share Units
2021-03-02$152.05/sh−2,355$358,085→ 62,860 total - Award
Restricted Share Units
2021-03-02+10,342→ 73,202 total - Award
Options to Buy Ordinary Shares
2021-03-02+19,004→ 19,004 totalExercise: $153.09Exp: 2031-03-01→ Ordinary Shares (19,004 underlying)
Footnotes (3)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units vested on February 27, 2021. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]Represents restricted share units that are scheduled to vest in equal installments on each of March 2, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates.
- [F3]Options to buy 19,004 ordinary shares will vest and become exercisable in equal installments on each of March 2, 2022, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001693530
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:44 PM ET
- Size
- 9.1 KB